Envoy Medical

01/12/2026

Life changes—and so do your needs.
As hearing loss increases with age, traditional solutions can feel inconvenient. That’s why Envoy Medical offers a fully implanted hearing device—designed for east, 24/7 hearing without external components.
Stay connected. Stay confident.

👉 Learn more: https://hubs.li/Q03-szNB0

01/05/2026

A new year is the perfect time to prioritize your hearing health.

Health and wellness isn’t just about exercise and nutrition—it’s also about connection, confidence, and fully engaging in the moments that matter. Treating hearing loss can help unlock all of that!

The first step? Understand your options. Learn more about the Esteem® fully implanted active middle ear implant here: https://hubs.li/Q03ZwFJ00

Explore what’s possible in 2026!

12/18/2025

Milestone Alert from Envoy Medical (NASDAQ: COCH)!

Our pivotal study for the fully implanted Acclaim® cochlear implant has reached midway enrollment and is on track to finish enrollment in early Q1 2026.

This innovative device uses our proprietary sensor with Nature’s Microphone™ technology—not a traditional microphone—to capture sound. It received FDA Breakthrough Device Designation in 2019.

Brent Lucas, our CEO, commented:

"We believe our fully implanted approach represents the future of hearing implants. The momentum in our pivotal study and the enthusiasm we are seeing from professionals in the field underscore the strong differentiation of our technology and our leadership as the industry shifts toward fully implanted solutions."

View full press release here:https://hubs.li/Q03YCR6l0
Learn more about the trial: https://hubs.li/Q03YCSZ20

CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

12/17/2025

🔹📢Big News from Envoy Medical!

We’re excited to share that Envoy Medical (NASDAQ: COCH) has secured a new patent in Australia —a step forward in hearing innovation!

What does this mean for people with hearing loss?
This patent covers an advancement that helps amplify sound right at the input source, reducing noise and interference.

What makes Envoy Medical and its current product design different?
Envoy Medical is the only company so far with a fully implanted active hearing device approved by the FDA (Esteem® active middle ear implant) and we’re investigating the Acclaim® fully implanted cochlear implant in a pivotal clinical trial.

🔹Proprietary Natures Microphone™ Sensor Technology – Unlike subdermal microphones, our sensor design is different.
🔹Replaceable Rechargeable Battery – Positioned in the chest to support easier maintenance.
🔹No External Wearable Components – No external sound processor or magnet required.

Read the press release here:https://hubs.li/Q03YxSC_0
Learn more about the trial: https://hubs.li/Q03YxL_H0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

12/11/2025

📢Update from Envoy Medical!

We’re excited to share an important milestone in our ongoing work to advance hearing health. Envoy Medical has completed the first set of activations in the final stage of its pivotal clinical study for the Acclaim® cochlear implant.

While we can’t share specific hearing results until the study is complete, we’re encouraged by the progress and grateful for the dedication of our clinical providers and participants. Every step forward brings us closer to understanding new possibilities for those living with significant hearing loss.

Thank you to everyone who continues to support our mission to improve quality of life through innovation in hearing health.

Read press release: https://hubs.li/Q03XRXBk0

Learn more about the study here: https://hubs.li/Q03XRQ8t0

CAUTION: The Acclaim® cochlear implant is an investigational device, limited by federal law to investigational use.

12/11/2025

🔥Join Our Fireside Chat Today!

Envoy Medical® (NASDAQ: COCH) will host a fireside chat featuring CEO Brent Lucas and Craig Eggert, the first patient to receive the Acclaim® cochlear implant, an investigational device currently in clinical trials and not yet approved for sale.

📅 Date: Thursday, December 11, 2025
🕓 Time: 4:30 P.M. ET
🔗 Register here: https://hubs.li/Q03WWlXk0

Hear firsthand about this groundbreaking technology and Envoy Medical’s mission to advance hearing health. A Q&A session will follow the discussion, and a recording will be available afterward.



CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.
Don’t miss our live fireside chat—save your spot today!

12/09/2025

When hearing loss and cognitive decline intersect, accessibility isn’t optional—it’s essential.

If you support someone with both hearing loss and cognitive challenges, you’ve likely seen how hard it is to keep them connected, engaged, and safe.

That’s why research like the work at the University at Buffalo and Auspex Medix is so important. They’re investigating an AI-powered hearing test that tracks pupil response instead of relying on verbal instructions—potentially making hearing assessment more accessible for people with memory or comprehension difficulties. It’s early-stage research, but it underscores a critical point: hearing care must work for everyone, not just those who can easily follow traditional testing.

At Envoy Medical, we share that commitment. Our fully implanted hearing technology is designed to eliminate common barriers—such as lost, forgotten, or difficult-to-manage external components—so loved ones can maintain greater independence, safety, and quality of life.

Learn more about the study here: https://hubs.li/Q03XtmRM0

From your perspective, what changes or innovations are most needed to make hearing care truly accessible for people living with cognitive challenges?

12/04/2025

Join Us for a Fireside Chat!

Envoy Medical® (NASDAQ: COCH) will host a fireside chat featuring CEO Brent Lucas and Craig Eggert, the first patient to receive the Acclaim® cochlear implant, an investigational device currently in clinical trials and not yet approved for sale.

📅 Date: Thursday, December 11, 2025
🕓 Time: 4:30 P.M. ET
🔗 Register here: https://hubs.li/Q03WWlD_0

Hear firsthand about this groundbreaking technology and Envoy Medical’s mission to advance hearing health. A Q&A session will follow the discussion, and a recording will be available afterward.



CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

12/02/2025

📢Exciting Milestone at Envoy Medical!

We’re proud to announce the grant of our 40th U.S. patent, marking another step forward in advancing hearing health innovation. This new patent strengthens our commitment to developing groundbreaking technologies designed to improve quality of life for those with hearing loss.

At Envoy Medical, we believe in pushing boundaries to deliver solutions that make a real difference. Thank you to our incredible team and partners who make this possible!

Learn more about this achievement: https://hubs.li/Q03WrD9G0

11/27/2025

🍂 Happy Thanksgiving from Envoy Medical! 🦃

At Envoy Medical, we’re thankful for the opportunity to help people reconnect with the sounds that matter most. This season reminds us how powerful hearing is in creating meaningful moments with family and friends.

From all of us at Envoy Medical, have a safe, joyful, and gratitude-filled holiday! 🧡

11/26/2025

Designed for Your Journey

Your hearing journey is unique—and so is our approach.
Envoy Medical CEO Brent Lucas shares updates on clinical trials and how innovation and break-through technology is designed to evolve with patient needs, offering confidence in long-term adaptability.

🎥 Watch now: https://hubs.li/Q03V_9Tk0



CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

Envoy Medical CEO Brent Lucas shares exciting updates on the company’s clinical trials and explains how future-proofing strategies are designed to give patie...

11/20/2025

🎉 A New Option for Living Life Fully 🎉

Imagine an implantable hearing option that removes the daily hassle of wearing external processors or wires. Envoy Medical (NASDAQ: COCH) is working toward that reality—and our latest patent brings us one step closer.

This innovative idea introduces a removable earplug paired with an implanted battery, giving patients flexibility and freedom while maintaining the benefits of a fully implanted system.

As CEO Brent Lucas says:

“We’re not just protecting today’s device, but where the future could head with implanted technologies.”

This is about options for patients to live life on their terms.

Learn more about our journey: https://hubs.li/Q03VfCJT0

👉 Learn more about our pivotal Acclaim® Cochlear Implant trial: https://hubs.li/Q03Vflv50



CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical secures a new U.S. patent for an innovative cochlear implant system featuring a removable earplug sensor and implanted battery, reinforcing their leadership in hearing device innovation.